CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
EVO-NANO focuses on creating a platform for the artificial evolution of nanoparticle-based drug delivery systems for cancer treatment. The project aims to enhance the effectiveness of nanoparticles in targeting tumors through innovative design and simulation techniques.
EVO-NANO aims to create an integrated cross-disciplinary platform for the artificial evolution and assessment of nanoparticle-based drug delivery systems.
Nanoparticles (NP) are increasingly being studied in cancer research for their ability to improve diagnosis accuracy and/or deliver tailored treatments directly to tumours.
However, their effective biodistribution is still a major limitation.
The challenge is to discover how to program collective behaviour of the trillions of NP interacting in…
UNIVERSITY OF NOVI SAD, FACULTY OF AGRICULTURE
UNIVERZITET U NOVOM SADU, POLJOPRIVREDNI FAKULTET NOVI SAD
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, Bristol
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Finland, Abo
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, Bristol
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
